Unknown

Dataset Information

0

IFN-gamma mediates the rejection of haematopoietic stem cells in IFN-gammaR1-deficient hosts.


ABSTRACT: BACKGROUND: Interferon-gamma receptor 1 (IFN-gammaR1) deficiency is a life-threatening inherited disorder, conferring predisposition to mycobacterial diseases. Haematopoietic stem cell transplantation (HSCT) is the only curative treatment available, but is hampered by a very high rate of graft rejection, even with intra-familial HLA-identical transplants. This high rejection rate is not seen in any other congenital disorders and remains unexplained. We studied the underlying mechanism in a mouse model of HSCT for IFN-gammaR1 deficiency. METHODS AND FINDINGS: We demonstrated that HSCT with cells from a syngenic C57BL/6 Ifngr1+/+ donor engrafted well and restored anti-mycobacterial immunity in naive, non-infected C57BL/6 Ifngr1-/- recipients. However, Ifngr1-/- mice previously infected with Mycobacterium bovis bacillus Calmette-Guérin (BCG) rejected HSCT. Like infected IFN-gammaR1-deficient humans, infected Ifngr1-/- mice displayed very high serum IFN-gamma levels before HSCT. The administration of a recombinant IFN-gamma-expressing AAV vector to Ifngr1-/- naive recipients also resulted in HSCT graft rejection. Transplantation was successful in Ifngr1-/- x Ifng-/- double-mutant mice, even after BCG infection. Finally, efficient antibody-mediated IFN-gamma depletion in infected Ifngr1-/- mice in vivo allowed subsequent engraftment. CONCLUSIONS: High serum IFN-gamma concentration is both necessary and sufficient for graft rejection in IFN-gammaR1-deficient mice, inhibiting the development of heterologous, IFN-gammaR1-expressing, haematopoietic cell lineages. These results confirm that IFN-gamma is an anti-haematopoietic cytokine in vivo. They also pave the way for HSCT management in IFN-gammaR1-deficient patients through IFN-gamma depletion from the blood. They further raise the possibility that depleting IFN-gamma may improve engraftment in other settings, such as HSCT from a haplo-identical or unrelated donor.

SUBMITTER: Rottman M 

PROVIDER: S-EPMC2214797 | biostudies-literature | 2008 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

IFN-gamma mediates the rejection of haematopoietic stem cells in IFN-gammaR1-deficient hosts.

Rottman Martin M   Soudais Claire C   Vogt Guillaume G   Renia Laurent L   Emile Jean-François JF   Decaluwe Hélène H   Gaillard Jean-Louis JL   Casanova Jean-Laurent JL  

PLoS medicine 20080101 1


<h4>Background</h4>Interferon-gamma receptor 1 (IFN-gammaR1) deficiency is a life-threatening inherited disorder, conferring predisposition to mycobacterial diseases. Haematopoietic stem cell transplantation (HSCT) is the only curative treatment available, but is hampered by a very high rate of graft rejection, even with intra-familial HLA-identical transplants. This high rejection rate is not seen in any other congenital disorders and remains unexplained. We studied the underlying mechanism in  ...[more]

Similar Datasets

| S-EPMC2935898 | biostudies-literature
| S-EPMC8570691 | biostudies-literature
| S-EPMC2683100 | biostudies-literature
| S-EPMC5872146 | biostudies-literature
| S-EPMC3270376 | biostudies-literature
| S-EPMC2643846 | biostudies-literature
| S-EPMC5241669 | biostudies-literature
| S-EPMC6227807 | biostudies-literature
| S-EPMC1215510 | biostudies-literature
| S-EPMC7606745 | biostudies-literature